Gilead Sciences Inc $74.08

up +0.22


24/4/2014 08:10 PM  |  NASDAQ : GILD  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get GILD Trend Analysis - it has outperformed the S&P 500 by 27%

Partner Headlines

  1. Stocks Fall as Traders Review Housing Data

    FoxBusiness
  2. Stocks Trading Lower In Afternoon Action

    IBD
  3. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  4. Morning Market Movers

    Benzinga
  5. How Did Analysts Get Gilead's Earnings Completely Wrong?

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. ETF Outlook For Wednesday, April 23, 2014 (MGC, IYZ, TAN, BBH, GILD, T)

    Benzinga
  8. Wall Street Steady After Six-Day Winning Streak

    FoxBusiness
  9. Stock Futures Dip as Traders Eye Corporate Earnings

    FoxBusiness
  10. Gilead Soars As Hep C Drug Shatters Views; Amgen Misses

    IBD
  11. Gilead, Illumina Crush Views

    IBD
  12. Gilead Crushes On Earnings, Quickly Gives Up Gains

    Benzinga
  13. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  14. Gilead Beats Q1 Estimates, Stock Halted Briefly

    Benzinga
  15. Rallying Ahead of Earnings

    FoxBusiness
  16. Nasdaq, S&P 500 On Track For Sixth Straight Gain

    IBD
  17. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  18. Earnings Scheduled For April 22, 2014

    Benzinga
  19. Gilead Sovaldi Drug Sales Key In Q1 Earnings Report

    IBD
  20. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  21. Gilead Q1 Its First Full Quarter With Sovaldi

    IBD
  22. Weekly Insider Sells Highlight: ATHN, GILD, JPM, WAG

    GuruFocus
  23. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  24. ObamaCare Hits UnitedHealth

    IBD
  25. UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts

    IBD
  26. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  27. China's Weibo Set to Debut After Cutting IPO Size

    FoxBusiness
  28. J&J Earnings Beat Estimates As Pharma Sales Shine

    IBD
  29. Stocks: Thin Gains; Yellen Coaxes Banks To Fortify

    IBD
  30. Markets Falling? Get Your Defense Ready

    Benzinga
  31. Stocks Jump In Weak Trade

    IBD
  32. US Stock Futures Slip Ahead Of Consumer Sentiment Report

    Benzinga
  33. Merck Hep-C Combo Scores

    IBD
  34. Merck Hep-C Combo Scores

    IBD
  35. HCV Rivalry Heats Up As Merck Combo Shines In Trial

    IBD
  36. Stocks Fall In Higher Volume; Alexion, Gilead Drop 7%

    IBD
  37. Nasdaq Leads Broad Rout In Stock Market

    IBD
  38. Merck Hepatitis C Combo Scores 98% Cure Rate

    IBD
  39. Five Star Stock Watch: Gilead Sciences

    Benzinga
  40. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  41. Biotechs Struggling To Find A Bottom

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Benzinga's Top #PreMarket Losers

    Benzinga
  44. UPDATE: TD Ameritrade Says IMX for Mar. Up to 5.87

    Benzinga
  45. GILEAD SCIENCES

    IBD
  46. Gilead's HepC Drug Sales May Be More Resilient Than Feared

    Benzinga
  47. Meet the Nasdaq Composite 2.0

    FoxBusiness
  48. Nasdaq Leads Another Up Day; S&P 500 Hits All-Time High

    IBD
  49. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  50. Gilead Adds To Biotech Woes

    IBD
Trading Center